Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS vaccines highlight the need to develop safe and effective vaccines against MERS. We have previously demonstrated that a receptor-binding domain (RBD)...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Wang, Yufei, Tai, Wanbo, Yang, Jie, Zhao, Guangyu, Sun, Shihui, Tseng, Chien-Te K., Jiang, Shibo, Zhou, Yusen, Du, Lanying, Gao, Jimin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2017
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512770/
https://ncbi.nlm.nih.gov/pubmed/28277821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1296994
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller